This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Arcutis Biotherapeutics, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovations of Archie W. Thurston, Jr.
Introduction
Archie W. Thurston, Jr. is a notable inventor based in San Diego, California. He has made significant contributions to the field of biotherapeutics, particularly in the development of topical formulations. His work focuses on improving therapeutic outcomes through innovative delivery methods.
Latest Patents
Thurston holds a patent for a "Topical roflumilast formulation having improved delivery and plasma half-life." This invention is directed towards enhancing the therapeutic effects of roflumilast by ensuring consistent delivery and extending the plasma half-life of the composition. The formulation includes key ingredients such as dicetyl phosphate, ceteth-10 phosphate, diethylene glycol monoethyl ether, and hexylene glycol.
Career Highlights
Thurston is currently associated with Arcutis Biotherapeutics, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatments that improve patient outcomes.
Collaborations
Some of his notable coworkers include David W. Osborne and Bhaskar Chaudhuri, who contribute to the innovative environment at Arcutis Biotherapeutics.
Conclusion
Archie W. Thurston, Jr. exemplifies the spirit of innovation in the biotherapeutics industry. His patent for a topical roflumilast formulation showcases his commitment to improving treatment efficacy. Through his work, he continues to make a positive impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile